Titre : Sarcoïdose pulmonaire

Sarcoïdose pulmonaire : Questions médicales fréquentes

Termes MeSH sélectionnés :

Pilot Projects
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Sarcoïdose pulmonaire : Questions médicales les plus fréquentes", "headline": "Sarcoïdose pulmonaire : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Sarcoïdose pulmonaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-28", "dateModified": "2025-02-22", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Sarcoïdose pulmonaire" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Sarcoïdose", "url": "https://questionsmedicales.fr/mesh/D012507", "about": { "@type": "MedicalCondition", "name": "Sarcoïdose", "code": { "@type": "MedicalCode", "code": "D012507", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.543.418.575" } } }, "about": { "@type": "MedicalCondition", "name": "Sarcoïdose pulmonaire", "alternateName": "Sarcoidosis, Pulmonary", "code": { "@type": "MedicalCode", "code": "D017565", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Robert P Baughman", "url": "https://questionsmedicales.fr/author/Robert%20P%20Baughman", "affiliation": { "@type": "Organization", "name": "Department of Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio." } }, { "@type": "Person", "name": "Dominique Valeyre", "url": "https://questionsmedicales.fr/author/Dominique%20Valeyre", "affiliation": { "@type": "Organization", "name": "Service de Pneumologie, INSERM UMR 1272, Université Sorbonne Paris Nord, AP-HP Hopital Avicenne, Bobigny, France." } }, { "@type": "Person", "name": "Jan C Grutters", "url": "https://questionsmedicales.fr/author/Jan%20C%20Grutters", "affiliation": { "@type": "Organization", "name": "Department of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands." } }, { "@type": "Person", "name": "Rohit Gupta", "url": "https://questionsmedicales.fr/author/Rohit%20Gupta", "affiliation": { "@type": "Organization", "name": "Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania." } }, { "@type": "Person", "name": "Hilario Nunes", "url": "https://questionsmedicales.fr/author/Hilario%20Nunes", "affiliation": { "@type": "Organization", "name": "AP-HP, Pulmonology Department, Avicenne Hospital, Bobigny, 93009, France; INSERM UMR 1272, Sorbonne Paris-Nord University, Bobigny, 93009, France. Electronic address: hilario.nunes@aphp.fr." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "SARS-CoV-2 rapid antigen screening of asymptomatic employees: a pilot project.", "datePublished": "2022-09-12", "url": "https://questionsmedicales.fr/article/36097245", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.17269/s41997-022-00691-z" } }, { "@type": "ScholarlyArticle", "name": "Health Disparities Investigator Development through a Team-Science Pilot Projects Program.", "datePublished": "2023-03-30", "url": "https://questionsmedicales.fr/article/37047951", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph20075336" } }, { "@type": "ScholarlyArticle", "name": "Global pen pal education intervention among student pharmacists: A pilot project.", "datePublished": "2022-09-22", "url": "https://questionsmedicales.fr/article/36153244", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cptl.2022.09.020" } }, { "@type": "ScholarlyArticle", "name": "A Disposable Diaper Collection Project in Langa, Cape Town, South Africa: A Pilot Study.", "datePublished": "2024-09-27", "url": "https://questionsmedicales.fr/article/39457265", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph21101292" } }, { "@type": "ScholarlyArticle", "name": "Changing the Playing Field: A Prehospital Blood Product Pilot Project in Rural North Georgia.", "datePublished": "2023-02-16", "url": "https://questionsmedicales.fr/article/36798046", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/00031348231157833" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système immunitaire", "item": "https://questionsmedicales.fr/mesh/D007154" }, { "@type": "ListItem", "position": 3, "name": "Hypersensibilité", "item": "https://questionsmedicales.fr/mesh/D006967" }, { "@type": "ListItem", "position": 4, "name": "Hypersensibilité retardée", "item": "https://questionsmedicales.fr/mesh/D006968" }, { "@type": "ListItem", "position": 5, "name": "Sarcoïdose", "item": "https://questionsmedicales.fr/mesh/D012507" }, { "@type": "ListItem", "position": 6, "name": "Sarcoïdose pulmonaire", "item": "https://questionsmedicales.fr/mesh/D017565" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Sarcoïdose pulmonaire - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Sarcoïdose pulmonaire", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Sarcoïdose pulmonaire", "description": "Comment diagnostiquer la sarcoïdose pulmonaire ?\nQuels tests sont utilisés pour le diagnostic ?\nLes tests sanguins sont-ils utiles ?\nQuelles sont les caractéristiques radiologiques ?\nLa biopsie est-elle toujours nécessaire ?", "url": "https://questionsmedicales.fr/mesh/D017565?mesh_terms=Pilot+Projects&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Sarcoïdose pulmonaire", "description": "Quels sont les symptômes courants ?\nLa fatigue est-elle un symptôme ?\nY a-t-il des symptômes systémiques ?\nLes symptômes varient-ils d'un patient à l'autre ?\nLes symptômes peuvent-ils s'aggraver ?", "url": "https://questionsmedicales.fr/mesh/D017565?mesh_terms=Pilot+Projects&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Sarcoïdose pulmonaire", "description": "Peut-on prévenir la sarcoïdose pulmonaire ?\nY a-t-il des facteurs environnementaux à éviter ?\nLe tabagisme influence-t-il la sarcoïdose ?\nDes vaccinations sont-elles recommandées ?\nLe stress a-t-il un impact sur la maladie ?", "url": "https://questionsmedicales.fr/mesh/D017565?mesh_terms=Pilot+Projects&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Sarcoïdose pulmonaire", "description": "Quels traitements sont disponibles ?\nY a-t-il des traitements alternatifs ?\nLes traitements sont-ils toujours nécessaires ?\nComment surveiller l'efficacité du traitement ?\nLes effets secondaires des traitements ?", "url": "https://questionsmedicales.fr/mesh/D017565?mesh_terms=Pilot+Projects&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Sarcoïdose pulmonaire", "description": "Quelles sont les complications possibles ?\nLa sarcoïdose peut-elle affecter d'autres organes ?\nComment prévenir les complications ?\nLes complications sont-elles réversibles ?\nQuels sont les signes d'alerte des complications ?", "url": "https://questionsmedicales.fr/mesh/D017565?mesh_terms=Pilot+Projects&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Sarcoïdose pulmonaire", "description": "Quels sont les facteurs de risque connus ?\nL'exposition professionnelle est-elle un facteur ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe sexe influence-t-il le risque ?\nL'âge est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D017565?mesh_terms=Pilot+Projects&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer la sarcoïdose pulmonaire ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des examens cliniques, radiologiques et histologiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent la radiographie thoracique, la tomodensitométrie et la biopsie." } }, { "@type": "Question", "name": "Les tests sanguins sont-ils utiles ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests sanguins peuvent aider à évaluer l'inflammation et la fonction pulmonaire." } }, { "@type": "Question", "name": "Quelles sont les caractéristiques radiologiques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "On observe souvent des adénopathies hilaires et des infiltrats pulmonaires." } }, { "@type": "Question", "name": "La biopsie est-elle toujours nécessaire ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, mais elle est souvent essentielle pour confirmer le diagnostic." } }, { "@type": "Question", "name": "Quels sont les symptômes courants ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent la toux, l'essoufflement et la douleur thoracique." } }, { "@type": "Question", "name": "La fatigue est-elle un symptôme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fatigue est fréquente et peut être sévère chez les patients." } }, { "@type": "Question", "name": "Y a-t-il des symptômes systémiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme la fièvre et la perte de poids peuvent survenir." } }, { "@type": "Question", "name": "Les symptômes varient-ils d'un patient à l'autre ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'intensité et la nature des symptômes peuvent varier considérablement." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils s'aggraver ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent s'aggraver avec le temps ou lors de poussées." } }, { "@type": "Question", "name": "Peut-on prévenir la sarcoïdose pulmonaire ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention connue pour la sarcoïdose." } }, { "@type": "Question", "name": "Y a-t-il des facteurs environnementaux à éviter ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Éviter l'exposition à des agents irritants ou allergènes peut être bénéfique." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il la sarcoïdose ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme peut aggraver les symptômes et la progression de la maladie." } }, { "@type": "Question", "name": "Des vaccinations sont-elles recommandées ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Aucune vaccination spécifique n'est recommandée pour prévenir la sarcoïdose." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur la maladie ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut exacerber les symptômes, mais il ne cause pas la sarcoïdose." } }, { "@type": "Question", "name": "Quels traitements sont disponibles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les corticostéroïdes sont le traitement principal pour réduire l'inflammation." } }, { "@type": "Question", "name": "Y a-t-il des traitements alternatifs ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des immunosuppresseurs peuvent être utilisés si les corticostéroïdes sont inefficaces." } }, { "@type": "Question", "name": "Les traitements sont-ils toujours nécessaires ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, certains patients peuvent ne pas nécessiter de traitement actif." } }, { "@type": "Question", "name": "Comment surveiller l'efficacité du traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La surveillance se fait par des examens cliniques et des tests de fonction pulmonaire." } }, { "@type": "Question", "name": "Les effets secondaires des traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les corticostéroïdes peuvent causer des effets secondaires comme la prise de poids." } }, { "@type": "Question", "name": "Quelles sont les complications possibles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la fibrose pulmonaire et l'insuffisance respiratoire." } }, { "@type": "Question", "name": "La sarcoïdose peut-elle affecter d'autres organes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut toucher les yeux, la peau, et le système nerveux." } }, { "@type": "Question", "name": "Comment prévenir les complications ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier et un traitement approprié peuvent aider à prévenir les complications." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Quels sont les signes d'alerte des complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme une aggravation de l'essoufflement ou de la douleur thoracique doivent alerter." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque connus ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, le sexe féminin et l'origine ethnique afro-américaine." } }, { "@type": "Question", "name": "L'exposition professionnelle est-elle un facteur ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines professions exposent à des agents susceptibles de déclencher la maladie." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un historique familial de sarcoïdose peut augmenter le risque de développer la maladie." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les femmes sont plus susceptibles de développer la sarcoïdose que les hommes." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la sarcoïdose est plus fréquente chez les adultes jeunes et d'âge moyen." } } ] } ] }

Sources (10000 au total)

SARS-CoV-2 rapid antigen screening of asymptomatic employees: a pilot project.

Rapid antigen screening can be effective in identifying infectious individuals in occupational settings to reduce transmission and outbreaks. We report results from a pilot project at the Greater Toro... An employee screening program was piloted between March 8 and May 28, 2021, to implement rapid antigen testing for asymptomatic employees. Recruitment targeted enrolment of 400 employees and yielded p... A total of 5117 tests were performed on 717 individuals over 12 weeks; 5091 tests were negative (99.5%), and 22 individuals tested positive (3.1% positivity rate). One hundred twenty-four (17%) comple... This pilot program identified 22 (3.1%) potentially infectious employees. Onsite testing was feasible and highly accepted by this group of employees who completed the survey. Education resulted in rea...

Global pen pal education intervention among student pharmacists: A pilot project.

Global health, a practice that prioritizes improving health and achieving health equity for all people worldwide, is a priority for pharmacists, schools, and pharmacy colleges. Several initiatives aim... This mixed-method study included assigned engagement within a required or elective didactic course, followed by a post-experience survey. Each student was pre-assigned a pen pal from a cohort of pharm... In total, 184 students completed the learning experience, and across both sites, 63 students completed the post-experience survey. The students' impressions of the PPP varied by site, yet most partici...

Changing the Playing Field: A Prehospital Blood Product Pilot Project in Rural North Georgia.

In Georgia, the paramedic's scope of practice prohibited the initiation of blood products. Due to the rural landscape in Georgia, one region's Regional Trauma Advisory Committee (RTAC) advocated expan... Approval was obtained from the state medical directors and the Office of EMS and Trauma. The project team addressed product selection, equipment, prehospital service selection, education, policies and... The pilot project began in spring of 2020, and as of January 2023, there have been 100 field initiations and no adverse effects, demonstrating the safety of paramedics to initiate blood products in th...

Community-supported teaching on the topic of transgender identity in undergraduate medical education - a pilot project.

Future physicians are insufficiently prepared for the topic of transgender identity during their studies. Relevant courses during undergraduate medical education are heterogeneous and not widely estab... During summer semester 2021 (SS21), the knowledge level on transgender identity of 134 medical students in their fifth clinical semester was evaluated (phase 1). In addition, knowledge gain on gender ... The students in SS21 did not feel sufficiently educated in the topic of transgender identity through their studies, but rated the relevance of the topic for their later profession as high. Learning ga... One 90-minutes seminar led to a significant learning gain regarding the topic of transgender identity. Community-supported teaching is a promising way to impart knowledge in a qualified manner: Medica...

Assessing tenant health amid social housing redevelopment: lessons from a pilot project.

To trial methods for a future longitudinal study to: a) assess how the redevelopment of a large social housing estate affects the health of tenants; and b) act on health needs identified throughout th... Participants recruited from the tenant population completed (online or face-to-face) a health questionnaire covering self-reported health status and behaviours, housing conditions, sense of community,... A total of 24 tenants were recruited for the pilot study against a target sample size of 50. The health questionnaire and referral process worked as expected, with no issues reported.... This pilot study successfully trialled methods for: a) assessing tenants' health; and b) referring those identified as being likely to have unmet health service needs to a community-based link worker,...

Developing a trigger tool to monitor adverse events during haemodialysis in children: a pilot project.

We developed a paediatric haemodialysis trigger tool (pHTT) for application per haemodialysis (HD) session in children receiving intermittent in-centre HD and systematically monitored adverse events.... Single-centre quality improvement study performed over two 8-week cycles. Data collected prospectively using a 'per-dialysis session' pHTT tool including 54 triggers across six domains, adapted from a... There were 241 triggers over 182 dialysis sessions, with 139 triggers in 91 HD sessions for 15 children, age range 28-205 months, over an 8-week period (first cycle) and 102 triggers in 91 HD sessions... This pilot study demonstrates potential benefits of a bedside tool to monitor adverse events during haemodialysis in children. Thus, following interventions informed by the pHTT, the harm rate per ses...

vSEMERA: pilot project assessing health profession students' experiences in an international virtual research program.

The "Virtual Semester for Medical Research Aachen" (vSEMERA) is an international, interdisciplinary, virtual education program developed for health profession students. The first edition (2021) was ho... vSEMERA was built on a virtual learning platform, the "vSEMERA-Campus", designed to foster students' learning process and social interactions. Maximum flexibility was offered through synchronous and a... The program received a rating of 4.38 out of 5 stars. While it met most expectations (4.29 out of 5), participants were unable to attend as many courses as intended (2.81 out of 5), mainly due to sche... vSEMERA represents a promising example of an online international learning and exchange program using pedagogical and technological elements of virtual collaboration and teaching. In addition to advan...